Awardee: Andrew Lieberman
Institution: University of Michigan
Award Amount: $53,000
Funding Period: January 1, 2016 - December 31, 2016
Characterization of NPC1-I1061T proteostasis machinery for development of NPC therapeutics
Previous
Previous
Exploring the impact of a TCF4 mutation on the physiology of inhibitory neurons of the prefrontal cortex.
Next
Next